Daniil Gataulin
Stock Analyst at Chardan Capital
(0)
# 4534
Out of 5,358 analysts
98
Total ratings
38.67%
Success rate
-13.65%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
QURE uniQure | Maintains: Buy | 38 38 | 17.26 | 120.16% | 4 | May 30, 2025 | |
ADVM Adverum Biotechnolog... | Maintains: Buy | 33 33 | 2.82 | 1070.21% | 7 | May 15, 2025 | |
MGTX MeiraGTx Hldgs | Maintains: Buy | 38 35 | 5.98 | 485.28% | 4 | May 14, 2025 | |
CRVO CervoMed | Maintains: Strong Buy | 14 15 | 7.55 | 98.68% | 6 | May 12, 2025 | |
OCGN Ocugen | Maintains: Buy | 7 7 | 1.06 | 560.38% | 11 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 28 33 | 19.99 | 65.08% | 7 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 33 27 | 8.94 | 202.01% | 11 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 8 4 | 0.3 | 1233.33% | 7 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 70 70 | 19.27 | 263.26% | 2 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 4 4 | 0.69 | 479.71% | 4 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 64 61 | 11.32 | 438.87% | 4 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 6 6 | 0.79 | 659.49% | 4 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 52 52 | 9.6 | 441.67% | 10 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 3 3 | 1.92 | 56.25% | 8 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 220 220 | 2.62 | 8296.95% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 2 | Jul 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 2 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 22 13 | n/a | n/a | 2 | Nov 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 5 3 | n/a | n/a | 2 | Sep 28, 2022 |